Alembic Ltd

ALEMBICLTD

Watchlist

AI Mode

‌

Market Cap

₹ 2,629 Cr

P/E

8.11

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

LOW RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Alembic Limited is a veteran manufacturer of bulk drugs and pharmaceuticals for human and animal healthcare in India. Founded in 1907, it has developed strong expertise in APIs and formulations, with significant production facilities in Vadodara and Solan.

Alembic's history of pharmaceutical innovation includes significant developments such as the launch of Erythromycin under Althrocin in 1972, which became a bestseller in India by 1997.

The company has diversified its business to include real estate and power generation sectors, leveraging its captive power plant operations and launching notable real estate projects like Samsara and VEDA.

Alembic's strategic ventures include the expansion of its API capacities and acquiring significant pharmaceutical and API facilities, boosting its operational capabilities over the years.

Sector

Realty

Industry

Construction - Factories / Offices / Commercial

Market Cap

2,629 Cr

Volatility

High Risk

P/E Ratio

8.1

Industry P/E

35.8

PEG Ratio

0.4

P/B Ratio

1.0

52W High

151.65

52W Low

85.55

Sales CAGR

40.89%

41.31%

23.81%

10Y

5.35%

Profit CAGR

55.67%

18.31%

8.70%

10Y

21.43%

ROE

TTM

12.78%

11.66%

11.71%

10Y

14.39%

ROCE

TTM

6.30%

5.17%

3.98%

10Y

4.08%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
AGIIL	261.20	3,190 Cr	41.52	9.47	0.04	22.82	20.95	6.08
RAYMONDREL	479.70	3,176 Cr	38.69	2.37	0.00	6.11	4.95	1.79
EFCIL	290.80	2,899 Cr	19.61	4.66	0.00	23.75	17.66	8.83
ALEMBICLTD	102.57	2,629 Cr	8.11	1.04	2.34	12.78	6.30	5.27
NATIONSTD	1302.70	2,626 Cr	238.76	9.46	0.00	3.96	5.54	3.87
KESAR	910.00	2,257 Cr	121.17	43.23	0.00	3.29	4.90	1.79
CAPACITE	260.80	2,191 Cr	10.99	1.21	0.00	11.00	15.10	5.43

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	37	32	39	49	51	53	58	60	50	56
Expenses	26	22	28	25	30	33	32	33	30	33
Operating Profit	11	10	12	24	20	20	26	27	20	23
OPM %	29.53	31.44	29.68	49.25	40.17	37.01	45.58	45.35	39.38	41.60
Other Income	2.63	48	2.23	2.04	1.96	66	4.37	2.96	3.59	65
Interest	0.13	0.13	0.37	0.48	0.49	0.67	0.69	0.62	0.59	0.56
Depreciation	1.83	1.86	2.66	1.48	2.50	2.68	2.69	2.75	2.79	2.82
Profit Before Tax	12	56	11	24	19	82	27	27	20	85
Tax %	13.77	7.73	8.83	12.13	10.07	5.52	4.75	11.78	10.10	10.29
Net Profit	9.96	52	9.91	21	17	77	26	24	18	76
EPS in Rs	1.73	3.53	2.39	2.81	2.17	4.71	2.55	2.67	2.40	5.00

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	144	125	124	74	74	78	127	157	222	221
Expenses	131	114	106	71	62	64	87	101	128	128
Operating Profit	14	11	18	3.28	11	14	40	57	94	93
OPM %	9.42	8.86	14.59	4.44	15.06	17.81	31.70	36.11	42.23	42.06
Other Income	25	37	29	93	10	89	54	55	75	77
Interest	0.16	0.17	0.22	0.29	0.36	0.39	0.47	1.11	2.47	2.57
Depreciation	5.09	3.78	2.63	3.23	3.94	4.86	6.72	7.84	11	11
Profit Before Tax	27	44	45	93	17	98	87	103	156	156
Tax %	-3.23	5.42	8.04	0.14	18.78	11.92	7.12	9.56	7.03	7.05
Net Profit	27	42	41	93	14	86	81	93	145	145
EPS in Rs	—	—	8.89	12.82	13.35	8.65	7.43	10.46	12.10	12.62
Dividend Payout %	3.68	3.28	2.42	4.68	1.50	20.81	29.65	22.94	19.83	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	53	53	53	51	51	51	51	51	51	51
Reserves	750	858	1,032	1,157	1,367	2,246	2,445	2,027	2,134	2,287
Borrowings	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	9.15	14
Other Liabilities	72	81	73	57	53	112	135	127	134	150
Total Liabilities	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503
Fixed Assets	146	148	132	131	131	134	134	132	131	135
CWIP	0.00	0.16	0.00	0.00	3.08	5.84	0.19	0.13	1.10	0.00
Investments	605	756	960	1,079	1,227	2,178	2,372	1,943	2,024	2,174
Other Assets	124	89	67	55	110	91	127	130	173	194
Total Assets	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	22	9.65	52	24	22	6.54	-2.18	-18	39	23
Cash from Investing Activity	4.68	-4.76	-47	-22	68	57	-35	19	7.30	26
Cash from Financing Activity	-25	-5.19	-4.96	-2.66	-89	-6.41	-15	-5.82	-46	-48
Net Cash Flow	1.68	-0.30	-0.02	-1.48	1.17	57	-52	-4.72	-0.24	0.33

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%
FIIs	0.82%	0.70%	0.72%	0.85%	0.89%	1.07%	1.42%	1.96%	1.78%	1.65%	1.50%	1.37%
DIIs	3.96%	3.96%	3.95%	3.41%	0.06%	0.05%	0.05%	0.09%	0.07%	0.05%	0.05%	0.05%
Public	24.33%	24.46%	24.45%	24.86%	28.17%	28.00%	27.64%	27.06%	27.27%	27.41%	27.57%	27.69%
Total Shareholders	83,659	82,339	81,732	82,947	94,012	99,130	98,478	1,02,249	1,07,423	1,06,732	1,07,510	1,06,470

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Oct 30, 2023	Crony vyapar pvt ltd	Bulk	Buy	82.68	15.05 Cr	18,20,809	0.70
Oct 30, 2023	Crony vyapar pvt ltd	Bulk	Sell	82.76	14.44 Cr	17,45,107	0.67
Oct 27, 2023	Crony vyapar pvt ltd	Bulk	Sell	81.19	10.64 Cr	13,09,952	0.51
Oct 27, 2023	Crony vyapar pvt ltd	Bulk	Buy	81.14	10.22 Cr	12,59,952	0.49
Oct 26, 2023	Crony vyapar pvt ltd	Bulk	Buy	78.45	14.27 Cr	18,18,732	0.70
Oct 26, 2023	Crony vyapar pvt ltd	Bulk	Sell	78.37	13.24 Cr	16,89,708	0.65
Oct 25, 2023	Crony vyapar pvt ltd	Bulk	Sell	79.43	17.18 Cr	21,63,165	0.84
Oct 25, 2023	Crony vyapar pvt ltd	Bulk	Buy	79.45	18.06 Cr	22,73,165	0.88
Oct 23, 2023	Crony vyapar pvt ltd	Bulk	Sell	82.64	24.39 Cr	29,50,822	1.14
Oct 23, 2023	Crony vyapar pvt ltd	Bulk	Buy	83.32	28.98 Cr	34,77,722	1.35

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Regulatory Filing

15 hours ago

Special Window for Share Transfer Requests

Alembic Limited announces the opening of a special window for re-lodgement of transfer requests of physical shares as per SEBI regulations, effective December 15, 2025.

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	37	32	39	49	51	53	58	60	50	56
Expenses	26	22	28	25	30	33	32	33	30	33
Operating Profit	11	10	12	24	20	20	26	27	20	23
OPM %	29.53	31.44	29.68	49.25	40.17	37.01	45.58	45.35	39.38	41.60
Other Income	2.63	48	2.23	2.04	1.96	66	4.37	2.96	3.59	65
Interest	0.13	0.13	0.37	0.48	0.49	0.67	0.69	0.62	0.59	0.56
Depreciation	1.83	1.86	2.66	1.48	2.50	2.68	2.69	2.75	2.79	2.82
Profit Before Tax	12	56	11	24	19	82	27	27	20	85
Tax %	13.77	7.73	8.83	12.13	10.07	5.52	4.75	11.78	10.10	10.29
Net Profit	9.96	52	9.91	21	17	77	26	24	18	76
EPS in Rs	1.73	3.53	2.39	2.81	2.17	4.71	2.55	2.67	2.40	5.00

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	144	125	124	74	74	78	127	157	222	221
Expenses	131	114	106	71	62	64	87	101	128	128
Operating Profit	14	11	18	3.28	11	14	40	57	94	93
OPM %	9.42	8.86	14.59	4.44	15.06	17.81	31.70	36.11	42.23	42.06
Other Income	25	37	29	93	10	89	54	55	75	77
Interest	0.16	0.17	0.22	0.29	0.36	0.39	0.47	1.11	2.47	2.57
Depreciation	5.09	3.78	2.63	3.23	3.94	4.86	6.72	7.84	11	11
Profit Before Tax	27	44	45	93	17	98	87	103	156	156
Tax %	-3.23	5.42	8.04	0.14	18.78	11.92	7.12	9.56	7.03	7.05
Net Profit	27	42	41	93	14	86	81	93	145	145
EPS in Rs	—	—	8.89	12.82	13.35	8.65	7.43	10.46	12.10	12.62
Dividend Payout %	3.68	3.28	2.42	4.68	1.50	20.81	29.65	22.94	19.83	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	53	53	53	51	51	51	51	51	51	51
Reserves	750	858	1,032	1,157	1,367	2,246	2,445	2,027	2,134	2,287
Borrowings	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	9.15	14
Other Liabilities	72	81	73	57	53	112	135	127	134	150
Total Liabilities	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503
Fixed Assets	146	148	132	131	131	134	134	132	131	135
CWIP	0.00	0.16	0.00	0.00	3.08	5.84	0.19	0.13	1.10	0.00
Investments	605	756	960	1,079	1,227	2,178	2,372	1,943	2,024	2,174
Other Assets	124	89	67	55	110	91	127	130	173	194
Total Assets	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,503

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	22	9.65	52	24	22	6.54	-2.18	-18	39	23
Cash from Investing Activity	4.68	-4.76	-47	-22	68	57	-35	19	7.30	26
Cash from Financing Activity	-25	-5.19	-4.96	-2.66	-89	-6.41	-15	-5.82	-46	-48
Net Cash Flow	1.68	-0.30	-0.02	-1.48	1.17	57	-52	-4.72	-0.24	0.33

Overview

Detailed Summary

Alembic's history of pharmaceutical innovation includes significant developments such as the launch of Erythromycin under Althrocin in 1972, which became a bestseller in India by 1997.

Alembic's strategic ventures include the expansion of its API capacities and acquiring significant pharmaceutical and API facilities, boosting its operational capabilities over the years.

Sector

Realty

Industry

Construction - Factories / Offices / Commercial

Market Cap

2,629 Cr

Volatility

High Risk

P/E Ratio

8.1

Industry P/E

35.8

PEG Ratio

0.4

P/B Ratio

1.0

52W High

151.65

52W Low

85.55

Sales CAGR

40.89%

41.31%

23.81%

10Y

5.35%

Profit CAGR

55.67%

18.31%

8.70%

10Y

21.43%

ROE

TTM

12.78%

11.66%

11.71%

10Y

14.39%

ROCE

TTM

6.30%

5.17%

3.98%

10Y

4.08%

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
AGIIL	261.20	3,190 Cr	41.52	9.47	0.04	22.82	20.95	6.08
RAYMONDREL	479.70	3,176 Cr	38.69	2.37	0.00	6.11	4.95	1.79
EFCIL	290.80	2,899 Cr	19.61	4.66	0.00	23.75	17.66	8.83
ALEMBICLTD	102.57	2,629 Cr	8.11	1.04	2.34	12.78	6.30	5.27
NATIONSTD	1302.70	2,626 Cr	238.76	9.46	0.00	3.96	5.54	3.87
KESAR	910.00	2,257 Cr	121.17	43.23	0.00	3.29	4.90	1.79
CAPACITE	260.80	2,191 Cr	10.99	1.21	0.00	11.00	15.10	5.43

Alembic Ltd

Alembic Ltd

ALEMBICLTD

AI Mode

Investment Checklist

Investment Checklist

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Projection

Actions

Announcements

Documents

AI Mode

AI Mode

Technicals

Projection

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Forecasts

Shareholdings

Shareholding History

Market Transactions

Documents

Alembic Ltd

ALEMBICLTD

AI Mode

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Investment Checklist

Peers

Price Chart Comparison

Announcements